Associations of ABO blood type and galactose-deficient immunoglobulin A1 with adverse outcomes in patients with IgA nephropathy
- 11 October 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 36 (2), 288-294
- https://doi.org/10.1093/ndt/gfz171
Abstract
Background Both ABO blood group antigens and pathogenic immunoglobulin A1 (IgA1) in patients with IgA nephropathy (IgAN) are influenced by modifications of N-acetylgalactosamine and galactose. The purpose of this study was to assess whether ABO blood type is associated with galactose-deficient IgA1 (Gd-IgA1) in the progression of kidney disease in patients with IgAN. Methods We enrolled 1313 IgAN patients with a median of 44 months follow-up and measured the plasma Gd-IgA1 levels. Multivariate Cox regression models were used to estimate the association between all variables and adverse outcomes. Using the propensity score matching method, 718 IgAN patients with blood type either A or B were selected, and their data were used to assess the association of blood type and Gd-IgA1/serum complement 3 (sC3) with outcomes. Results We found that the risk of adverse outcomes was significantly higher in patients with blood type A than in those with type B (hazard ratio = 1.82, 95% confidence interval 1.23–2.71; P = 0.003) after multivariate adjustment. The Gd-IgA1 levels showed trends similar to the multivariate-adjusted event-free curves for the blood types. However, this higher risk of adverse outcomes in type A than in type B patients was no longer significant after the addition of Gd-IgA1/sC3 to the model. Conclusions IgAN patients with blood type A had a higher risk of adverse outcomes than those with type B, and this risk was associated with Gd-IgA1/sC3. Thus, the ABO blood type may provide a reference for the prognostic factors for individuals with IgAN.Funding Information
- China Clinical Research and Capital Health Development Research Project (CD-2018-2-4073)
- Peking University Health Sciences Center Joint Institute for Translational
- China National Key Research and Development Plan (2018YFC1314004)
- China National Natural Science Fund (81670649)
This publication has 34 references indexed in Scilit:
- A New Chemical Approach to Human ABO Histo-Blood Group Type 2 AntigensMolecules, 2013
- The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progressionKidney International, 2012
- Association between the ABO blood group and the human intestinal microbiota compositionBMC Microbiology, 2012
- Pathogenesis of IgA nephropathyNature Reviews Nephrology, 2012
- Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch–Schönlein purpura nephritisKidney International, 2011
- ABO blood group and cancerEuropean Journal of Cancer, 2010
- Quantitation of Saccharide Compositions of O-glycans by Mass Spectrometry of Glycopeptides and Its Application to Rheumatoid ArthritisJournal of Proteome Research, 2010
- Evolutionary dynamics of the human ABO geneHuman Genetics, 2008
- Significance of serum IgA levels and serum IgA/C3 ratio in diagnostic analysis of patients with IgA nephropathyJournal of Clinical Laboratory Analysis, 2003
- A retrospective analysis of the natural history of primary IgA nephropathy worldwideThe American Journal of Medicine, 1990